Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein

2 Sept 2022

Abstract excerpt

The etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the best drug targets, viral oncoprotein E6 has been identified as a key factor in cell immortalization and tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Hepatitis B Virus Studies
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36146532
DOI: 10.3390/vaccines10091452

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 ProteinPMID 36146532Read ↗

Identification and Characterization of Small Molecule Human Papillomavirus E6 InhibitorsSemantic proximity Read ↗

Taxifolin and Lucidin as Potential E6 Protein Inhibitors: p53 Function Re-Establishment and Apoptosis Induction in Cervical Cancer CellsSemantic proximity Read ↗

Structure Based Identification and Characterization of Flavonoids That Disrupt Human Papillomavirus-16 E6 FunctionSemantic proximity Read ↗

In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug responseSemantic proximity Read ↗

Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancerSemantic proximity Read ↗

Covalent Inhibition of the Human Papillomavirus Type 16 E6 Protein Restores p53 and Suppresses HPV-Driven TumorigenesisSemantic proximity Read ↗

Small Molecule Inhibitors of Human Papillomavirus Protein - Protein InteractionsSemantic proximity Read ↗

In silico Study of Natural inhibitors for Human papillomavirus-18 E6 proteinSemantic proximity Read ↗

A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growthSemantic proximity Read ↗

Virtual Screening of Kaempferia galanga L. Bioactive Compounds as HPV-16 Antiviral Mechanism Through E6 Inhibitor ActivitySemantic proximity Read ↗

Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell LinesSemantic proximity Read ↗

Pharmacophore based virtual screening for identification of effective inhibitors to compact HPV 16 E6 a triggered cervical cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.